Home » News » Drug Sponsors » Pfizer collaborates on drugs for Russian market

Pfizer collaborates on drugs for Russian market

Friday, July 1, 2011

Pfizer will work with a Russian venture capital company to research and market new drugs in Russia and surrounding countries, according to the Associated Press.

Pfizer said it will work with ChemRar High Tech Center to explore research, development and marketing of drugs and vaccines to treat heart and metabolic illnesses, infectious diseases and cancer. It said those conditions are a high priority for the Russian Federation health care system.

Pfizer and ChemRar did not disclose any financial terms. The partnership plans to seek technology transfer and licensing deals for drugs in Pfizer’s pipeline of developing drugs.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!